Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · PENFIELD, NY · NPI 1801822333
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1090 | 319 |
| Amlodipine Besylate | Amlodipine Besylate | 547 | 155 |
| Levothyroxine Sodium | Levothyroxine Sodium | 517 | 141 |
| Losartan Potassium | Losartan Potassium | 493 | 153 |
| Metoprolol Succinate | Metoprolol Succinate | 283 | 82 |
| Omeprazole | Omeprazole | 277 | 88 |
| Lisinopril | Lisinopril | 255 | 75 |
| Metformin Hcl | Metformin Hcl | 246 | 74 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 246 | 80 |
| Simvastatin | Simvastatin | 236 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 232 | 74 |
| Sertraline Hcl | Sertraline Hcl | 214 | 54 |
| Eliquis | Apixaban | 202 | 51 |
| Tamsulosin Hcl | Tamsulosin Hcl | 186 | 53 |
| Allopurinol | Allopurinol | 169 | 44 |
| Gabapentin | Gabapentin | 156 | 49 |
| Lorazepam | Lorazepam | 151 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 146 | 38 |
| Prednisone | Prednisone | 137 | 95 |
| Ozempic | Semaglutide | 123 | 23 |
| Torsemide | Torsemide | 118 | 35 |
| Famotidine | Famotidine | 113 | 34 |
| Zolpidem Tartrate | Zolpidem Tartrate | 107 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 106 | 35 |
| Alprazolam | Alprazolam | 99 | 24 |
| Meloxicam | Meloxicam | 95 | 23 |
| Bupropion Xl | Bupropion Hcl | 92 | 24 |
| Atenolol | Atenolol | 91 | 26 |
| Furosemide | Furosemide | 89 | 27 |
| Jardiance | Empagliflozin | 89 | 22 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 88 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 87 | 31 |
| Glimepiride | Glimepiride | 83 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 72 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 72 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 33 |
| Donepezil Hcl | Donepezil Hcl | 67 | 21 |
| Metformin Hcl Er | Metformin Hcl | 67 | 24 |
| Warfarin Sodium | Warfarin Sodium | 67 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 61 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 59 | 49 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 58 | 20 |
| Chlorthalidone | Chlorthalidone | 57 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 56 | 17 |
| Trazodone Hcl | Trazodone Hcl | 55 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 53 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 53 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 50 | suppressed |
| Trulicity | Dulaglutide | 50 | 11 |
| Lansoprazole | Lansoprazole | 49 | 14 |
| Clonazepam | Clonazepam | 48 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 46 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | 13 |
| Lovastatin | Lovastatin | 44 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 44 | 12 |
| Spironolactone | Spironolactone | 44 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 39 | 20 |
| Ipratropium Bromide | Ipratropium Bromide | 38 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 38 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 37 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 36 | 17 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 35 | 35 |
| Ezetimibe | Ezetimibe | 35 | 14 |
| Glipizide Er | Glipizide | 35 | suppressed |
| Mirtazapine | Mirtazapine | 35 | suppressed |
| Naproxen | Naproxen | 35 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 35 | 12 |
| Diazepam | Diazepam | 33 | 14 |
| Finasteride | Finasteride | 32 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 32 | 12 |
| Mometasone Furoate | Mometasone Furoate | 32 | 19 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | 24 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Potassium Chloride | Potassium Chloride | 29 | suppressed |
| Celecoxib | Celecoxib | 28 | 11 |
| Cephalexin | Cephalexin | 28 | 25 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | suppressed |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | 12 |
| Montelukast Sodium | Montelukast Sodium | 26 | suppressed |
| Felodipine Er | Felodipine | 25 | suppressed |
| Carvedilol | Carvedilol | 24 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 23 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 22 | suppressed |
| Rybelsus | Semaglutide | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | suppressed |
| Baclofen | Baclofen | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Fluocinonide | Fluocinonide | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Nystatin | Nystatin | 17 | 12 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Invokana | Canagliflozin | 16 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Nortrel | Norethindrone-Ethin. Estradiol | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Wegovy | Semaglutide | 14 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 13 | 13 |
| Pregabalin | Pregabalin | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Unifine Pentips Plus | Pen Needle, Diabetic | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error